Rein Therapeutics, Inc. Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
Rein Therapeutics, Inc. (RNTX) had Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals of $271.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals · last filed 2026-03-26
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $271.00K.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $340.00K.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $251.00K.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $61.00K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals |
|---|---|
| 2025-12-31 | $271.00K 10-K · filed 2026-03-26 |
| 2024-12-31 | $340.00K 10-K · filed 2026-03-26 |
| 2023-12-31 | $251.00K 10-K · filed 2025-04-07 |
| 2022-12-31 | $61.00K 10-K · filed 2024-04-15 |
| 2021-12-31 | $290.00K 10-K · filed 2023-03-20 |
| 2020-12-31 | $265.00K 10-K · filed 2022-03-28 |
| 2019-12-31 | $312.00K 10-K · filed 2021-03-24 |
| 2018-12-31 | $396.00K 10-K · filed 2020-03-30 |
| 2017-12-31 | $396.00K 10-K · filed 2019-03-29 |
| 2016-12-31 | $457.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |